Seer Q1 2026 revenue $2.8M (-34% YoY); reaffirms FY2026 guidance of $16M-$18M

Seer, Inc.

Revenue $2.8M, down 34% from $4.2M YoY, driven by depressed academic funding and competitive activity.
Net loss $16.8M vs $19.9M prior year; operating expenses down 20% to $18.2M.
Reaffirmed full year 2026 revenue guidance of $16M-$18M (3% growth at midpoint).
Ended Q1 with ~$220M cash and investments; repurchased ~1.5M shares in the quarter.
Appointed Anthony (Tony) Bazarko as CCO; secured collaboration with Precision Health Research, Singapore (10,000 samples).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.